Shareholder Jiangsu Baixing of Lifecome Biochemistry (002868.SZ) plans to reduce its shareholding by no more than 3%.

ST LvKang (002868.SZ) announced that the company's shareholder, Jiangsu Baixing Industrial Investment Group Co., Ltd. (referred to as "Jiangsu Baixing"), plans to reduce its holding of the company's shares by a total of no more than 4.6625 million shares (3% of the company's total share capital) through centralized bidding and block trading from December 30, 2025 to March 29, 2026.